Want to see IN:ZYDUSLIFE full AI Analyst Report?
Total Valuation
Zydus Lifesciences Limited has a market cap or net worth of ₹1.15T. The enterprise value is ₹954.56K.
Market Cap₹1.15T
Enterprise Value₹954.56K
Share Statistics
Zydus Lifesciences Limited has 997,503,850 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding997,503,850
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Zydus Lifesciences Limited’s return on equity (ROE) is 0.19 and return on invested capital (ROIC) is 9.72%.
Return on Equity (ROE)0.19
Return on Assets (ROA)0.10
Return on Invested Capital (ROIC)9.72%
Return on Capital Employed (ROCE)0.16
Revenue Per Employee9.06M
Profits Per Employee1.68M
Employee Count29,980
Asset Turnover0.52
Inventory Turnover2.33
Valuation Ratios
The current PE Ratio of Zydus Lifesciences Limited is 25.1. Zydus Lifesciences Limited’s PEG ratio is 1.53.
PE Ratio25.1
PS Ratio3.23
PB Ratio3.23
Price to Fair Value3.23
Price to FCF-72.89
Price to Operating Cash Flow119.79
PEG Ratio1.53
Income Statement
In the last 12 months, Zydus Lifesciences Limited had revenue of 271.48B and earned 50.40B in profits. Earnings per share was 50.09.
Revenue271.48B
Gross Profit140.30B
Operating Income57.87B
Pretax Income67.18B
Net Income50.40B
EBITDA85.65B
Earnings Per Share (EPS)50.09
Cash Flow
In the last 12 months, operating cash flow was 9.46B and capital expenditures -8.68B, giving a free cash flow of 785.00M billion.
Operating Cash Flow9.46B
Free Cash Flow785.00M
Free Cash Flow per Share0.79
Dividends & Yields
Zydus Lifesciences Limited pays an annual dividend of ₹1, resulting in a dividend yield of 0.09%
Dividend Per Share₹1
Dividend Yield0.09%
Payout Ratio2.23%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.45
52-Week Price Change8.72%
50-Day Moving Average1.14K
200-Day Moving Average993.55
Relative Strength Index (RSI)47.59
Average Volume (3m)103.22K
Important Dates
Zydus Lifesciences Limited upcoming earnings date is Nov 14, 2026, TBA (Confirmed).
Last Earnings DateAug 11, 2026
Next Earnings DateNov 14, 2026
Ex-Dividend Date―
Financial Position
Zydus Lifesciences Limited as a current ratio of 1.27, with Debt / Equity ratio of 0.00%
Current Ratio1.27
Quick Ratio0.91
Debt to Market Cap0.13
Net Debt to EBITDA1.29
Interest Coverage Ratio13.18
Taxes
In the past 12 months, Zydus Lifesciences Limited has paid 15.95B in taxes.
Income Tax15.95B
Effective Tax Rate0.24
Enterprise Valuation
Zydus Lifesciences Limited EV to EBITDA ratio is 11.53, with an EV/FCF ratio of -82.10.
EV to Sales3.64
EV to EBITDA11.53
EV to Free Cash Flow-82.10
EV to Operating Cash Flow45.06
Balance Sheet
Zydus Lifesciences Limited has ₹49.71B in cash and marketable securities with ₹0.00 in debt, giving a net cash position of ₹49.71B billion.
Cash & Marketable Securities₹49.71B
Total Debt₹0.00
Net Cash₹49.71B
Net Cash Per Share₹49.84
Tangible Book Value Per Share₹120.99
Margins
Gross margin is 50.17%, with operating margin of 21.31%, and net profit margin of 18.56%.
Gross Margin50.17%
Operating Margin21.31%
Pretax Margin24.75%
Net Profit Margin18.56%
EBITDA Margin31.55%
EBIT Margin26.36%
Analyst Forecast
The average price target for Zydus Lifesciences Limited is ₹1,240.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target₹1,240.00
Price Target Upside11.82% Upside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast21.11%
EPS Growth Forecast-1.28%